We are live on ! Find out more
RBC

Ronald Blue & Co Portfolio holdings

AUM $3.1B
1-Year Est. Return 12.82%
This Fund
S&P 500
This Quarter Est. Return
+1.53%
1 Year Est. Return
+12.82%
3 Year Est. Return
+2.44%
5 Year Est. Return
10 Year Est. Return
AUM
$2.1B
AUM Growth
+$39.4M
Cap. Flow
+$8.53M
Cap. Flow %
0.41%
Top 10 Hldgs %
86.38%
Holding
384
New
35
Increased
147
Reduced
150
Closed
31

Sector Composition

Rank Sector Weight
1 Healthcare 2.05%
2 Financials 1.8%
3 Consumer Staples 1.6%
4 Energy 1.58%
5 Industrials 1.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DEO icon
101
Diageo
DEO
$49B
$887K 0.04%
8,030
+1,010
+14% +$116K
RIO icon
102
Rio Tinto
RIO
$158B
$878K 0.04%
21,219
+2,336
+12% +$106K
UNH icon
103
UnitedHealth
UNH
$376B
$877K 0.04%
7,416
+201
+3% +$22.3K
CMCSA icon
104
Comcast
CMCSA
$85B
$876K 0.04%
31,030
+1,550
+5% +$44.6K
DD
105
DELISTED
Du Pont De Nemours E I
DD
$862K 0.04%
12,708
-1,520
-11% -$108K
MCK icon
106
McKesson
MCK
$100B
$858K 0.04%
3,795
-42
-1% -$9.32K
SNY icon
107
Sanofi
SNY
$103B
$857K 0.04%
17,321
+2,862
+20% +$137K
CVS icon
108
CVS Health
CVS
$133B
$846K 0.04%
8,195
-26
-0.3% -$2.63K
ARMH
109
DELISTED
ARM HOLDINGS PLC ADS
ARMH
$843K 0.04%
17,104
+826
+5% +$41.1K
SLV icon
110
iShares Silver Trust
SLV
$28B
$802K 0.04%
50,330
-83,095
-62% -$1.33M
NKE icon
111
Nike
NKE
$61.9B
$796K 0.04%
15,874
+1,872
+13% +$89.5K
GILD icon
112
Gilead Sciences
GILD
$162B
$788K 0.04%
8,033
-1,161
-13% -$118K
TFCFA
113
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
$788K 0.04%
23,285
+347
+2% +$12K
ADP icon
114
Automatic Data Processing
ADP
$106B
$782K 0.04%
9,132
+3,132
+52% +$270K
NSC icon
115
Norfolk Southern
NSC
$75.4B
$780K 0.04%
7,577
+851
+13% +$91K
DJP icon
116
iPath Bloomberg Commodity Index Total Return ETN due 12 June 2036
DJP
$800M
$761K 0.04%
+27,458
New +$791K
MON
117
DELISTED
Monsanto Co
MON
$760K 0.04%
6,757
+1,117
+20% +$133K
BCE icon
118
BCE
BCE
$20.2B
$750K 0.04%
17,713
+1,412
+9% +$62.9K
TXN icon
119
Texas Instruments
TXN
$252B
$750K 0.04%
13,115
+661
+5% +$37.1K
NVO
120
Novo Nordisk
NVO
$208B
$745K 0.04%
27,912
+3,396
+14% +$78.2K
BIIB icon
121
Biogen
BIIB
$30B
$737K 0.04%
1,745
-270
-13% -$106K
BP icon
122
BP
BP
$116B
$734K 0.04%
22,606
+285
+1% +$9.33K
AMZN icon
123
Amazon
AMZN
$2.92T
$728K 0.03%
39,120
+400
+1% +$7.03K
KMB icon
124
Kimberly-Clark
KMB
$36.3B
$720K 0.03%
6,717
-248
-4% -$27.4K
SBUX icon
125
Starbucks
SBUX
$120B
$716K 0.03%
15,126
-306
-2% -$13.7K

Similar funds

Ronald Blue & Co's Q1 2015 Portfolio in Review

As of Q1 2015, Ronald Blue & Co held 384 positions worth $2.1B, up 1.9% from $2.06B the previous quarter. Its ten largest holdings account for 86% of the portfolio.

Ronald Blue & Co's Q1 2015 filing shows 35 new, 147 increased, 150 reduced and 31 closed positions. Its largest new stake was Vanguard FTSE Europe ETF: 130,341 shares worth $7.07M. The largest sale was iShares MSCI ACWI ex US ETF, an estimated $75M.

By sector, the portfolio is most concentrated in Healthcare at 2% of assets, down from 2.1% a quarter earlier, followed by Financials and Consumer Staples.

  • Ronald Blue & Co's largest Q1 2015 buy was Vanguard FTSE Europe ETF: 130,341 shares worth $7.07M.
  • Ronald Blue & Co added most to Vident US Equity Strategy ETF in Q1 2015, an estimated $55.3M increase.
  • Ronald Blue & Co's biggest Q1 2015 reduction was iShares MSCI ACWI ex US ETF, cutting an estimated $75M.
  • Ronald Blue & Co fully exited PRECISION CASTPARTS CORP in Q1 2015, selling an estimated $463K.
  • Ronald Blue & Co's ten largest holdings make up 86% of its $2.1B portfolio in Q1 2015.
  • Ronald Blue & Co opened 35 new positions and closed 31 in Q1 2015.
  • Ronald Blue & Co's portfolio value rose 1.9% quarter-over-quarter to $2.1B.

Based on Ronald Blue & Co's 13F filing for Q1 2015, filed 12 May 2015.